Stereotaxis completes Robocath acquisition to expand endovascular robotics platform
Stereotaxis, Inc. has completed its acquisition of French vascular robotics developer Robocath, bringing together two different approaches to controlling medical devices during minimally invasive endovascular procedures. Robocath will be integrated into the United States-based surgical robotics company, which plans to combine its magnetic navigation technology with Robocath’s mechanically controlled platforms for interventional cardiology, neurointerventions and